カテゴリー： QYResearch, 世界, 医療/バイオ

世界の脳がん治療市場インサイト及び予測（化学療法、免疫療法、標的療法、その他）

◆英語タイトル：Global Brain Cancer Treatment Market Insights, Forecast to 2028
	◆商品コード：QY22JL3466 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：109 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、脳がん治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳がん治療の世界市場のxxx％を占める「化学療法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「原発性脳腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
脳がん治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの脳がん治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

脳がん治療のグローバル主要企業には、Novartis AG、F. Hoffmann-La Roche Ltd、Pfizer,Inc、Y-mAbs Therapeutics,Inc、Merck & Co.Inc、Johnson & Johnson、AstraZeneca、Bristol-Myers Squibb、Amgen Inc、GlaxoSmith Kline PLCなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

脳がん治療市場は、種類と用途によって区分されます。世界の脳がん治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
化学療法、免疫療法、標的療法、その他

【用途別セグメント】
原発性脳腫瘍、続発性脳腫瘍

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 脳がん治療製品概要
- 種類別市場（化学療法、免疫療法、標的療法、その他）
- 用途別市場（原発性脳腫瘍、続発性脳腫瘍）
- 調査の目的
・エグゼクティブサマリー
- 世界の脳がん治療販売量予測2017-2028
- 世界の脳がん治療売上予測2017-2028
- 脳がん治療の地域別販売量
- 脳がん治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脳がん治療販売量
- 主要メーカー別脳がん治療売上
- 主要メーカー別脳がん治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（化学療法、免疫療法、標的療法、その他）
- 脳がん治療の種類別販売量
- 脳がん治療の種類別売上
- 脳がん治療の種類別価格
・用途別市場規模（原発性脳腫瘍、続発性脳腫瘍）
- 脳がん治療の用途別販売量
- 脳がん治療の用途別売上
- 脳がん治療の用途別価格
・北米市場
- 北米の脳がん治療市場規模（種類別、用途別）
- 主要国別の脳がん治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの脳がん治療市場規模（種類別、用途別）
- 主要国別の脳がん治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の脳がん治療市場規模（種類別、用途別）
- 主要国別の脳がん治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の脳がん治療市場規模（種類別、用途別）
- 主要国別の脳がん治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの脳がん治療市場規模（種類別、用途別）
- 主要国別の脳がん治療市場規模（トルコ、サウジアラビア）
・企業情報
Novartis AG、F. Hoffmann-La Roche Ltd、Pfizer,Inc、Y-mAbs Therapeutics,Inc、Merck & Co.Inc、Johnson & Johnson、AstraZeneca、Bristol-Myers Squibb、Amgen Inc、GlaxoSmith Kline PLC
・産業チェーン及び販売チャネル分析
- 脳がん治療の産業チェーン分析
- 脳がん治療の原材料
- 脳がん治療の生産プロセス
- 脳がん治療の販売及びマーケティング
- 脳がん治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脳がん治療の産業動向
- 脳がん治療のマーケットドライバー
- 脳がん治療の課題
- 脳がん治療の阻害要因
・主な調査結果

Market Analysis and Insights: Global Brain Cancer Treatment Market
The global Brain Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Chemotherapy accounting for % of the Brain Cancer Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Primary Brain Cancer segment is altered to an % CAGR throughout this forecast period.
China Brain Cancer Treatment market size is valued at US$ million in 2021, while the North America and Europe Brain Cancer Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Brain Cancer Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brain Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brain Cancer Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brain Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brain Cancer Treatment market.
Global Brain Cancer Treatment Scope and Market Size
Brain Cancer Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Brain Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Others
Segment by Application
Primary Brain Cancer
Secondary Brain Cancer
By Company
Novartis AG
F. Hoffmann-La Roche Ltd
Pfizer,Inc
Y-mAbs Therapeutics,Inc
Merck & Co.Inc
Johnson & Johnson
AstraZeneca
Bristol-Myers Squibb
Amgen Inc
GlaxoSmith Kline PLC
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Brain Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Primary Brain Cancer
1.3.3 Secondary Brain Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Treatment Market Perspective (2017-2028)
2.2 Brain Cancer Treatment Growth Trends by Region
2.2.1 Brain Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Brain Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 Brain Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 Brain Cancer Treatment Market Dynamics
2.3.1 Brain Cancer Treatment Industry Trends
2.3.2 Brain Cancer Treatment Market Drivers
2.3.3 Brain Cancer Treatment Market Challenges
2.3.4 Brain Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Treatment Players by Revenue
3.1.1 Global Top Brain Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global Brain Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Brain Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Cancer Treatment Revenue
3.4 Global Brain Cancer Treatment Market Concentration Ratio
3.4.1 Global Brain Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Treatment Revenue in 2021
3.5 Brain Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Brain Cancer Treatment Product Solution and Service
3.7 Date of Enter into Brain Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Treatment Breakdown Data by Type
4.1 Global Brain Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global Brain Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Brain Cancer Treatment Breakdown Data by Application
5.1 Global Brain Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global Brain Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Brain Cancer Treatment Market Size (2017-2028)
6.2 North America Brain Cancer Treatment Market Size by Type
6.2.1 North America Brain Cancer Treatment Market Size by Type (2017-2022)
6.2.2 North America Brain Cancer Treatment Market Size by Type (2023-2028)
6.2.3 North America Brain Cancer Treatment Market Share by Type (2017-2028)
6.3 North America Brain Cancer Treatment Market Size by Application
6.3.1 North America Brain Cancer Treatment Market Size by Application (2017-2022)
6.3.2 North America Brain Cancer Treatment Market Size by Application (2023-2028)
6.3.3 North America Brain Cancer Treatment Market Share by Application (2017-2028)
6.4 North America Brain Cancer Treatment Market Size by Country
6.4.1 North America Brain Cancer Treatment Market Size by Country (2017-2022)
6.4.2 North America Brain Cancer Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Brain Cancer Treatment Market Size (2017-2028)
7.2 Europe Brain Cancer Treatment Market Size by Type
7.2.1 Europe Brain Cancer Treatment Market Size by Type (2017-2022)
7.2.2 Europe Brain Cancer Treatment Market Size by Type (2023-2028)
7.2.3 Europe Brain Cancer Treatment Market Share by Type (2017-2028)
7.3 Europe Brain Cancer Treatment Market Size by Application
7.3.1 Europe Brain Cancer Treatment Market Size by Application (2017-2022)
7.3.2 Europe Brain Cancer Treatment Market Size by Application (2023-2028)
7.3.3 Europe Brain Cancer Treatment Market Share by Application (2017-2028)
7.4 Europe Brain Cancer Treatment Market Size by Country
7.4.1 Europe Brain Cancer Treatment Market Size by Country (2017-2022)
7.4.2 Europe Brain Cancer Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific Brain Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Brain Cancer Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Brain Cancer Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Brain Cancer Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Brain Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Brain Cancer Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Brain Cancer Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Brain Cancer Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Brain Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Brain Cancer Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Brain Cancer Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Brain Cancer Treatment Market Size (2017-2028)
9.2 Latin America Brain Cancer Treatment Market Size by Type
9.2.1 Latin America Brain Cancer Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Brain Cancer Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Brain Cancer Treatment Market Share by Type (2017-2028)
9.3 Latin America Brain Cancer Treatment Market Size by Application
9.3.1 Latin America Brain Cancer Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Brain Cancer Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Brain Cancer Treatment Market Share by Application (2017-2028)
9.4 Latin America Brain Cancer Treatment Market Size by Country
9.4.1 Latin America Brain Cancer Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Brain Cancer Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa Brain Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Brain Cancer Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Brain Cancer Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Brain Cancer Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Brain Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Brain Cancer Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Brain Cancer Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Brain Cancer Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Brain Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Brain Cancer Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Brain Cancer Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Brain Cancer Treatment Introduction
11.1.4 Novartis AG Revenue in Brain Cancer Treatment Business (2017-2022)
11.1.5 Novartis AG Recent Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Brain Cancer Treatment Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Ltd Recent Developments
11.3 Pfizer,Inc
11.3.1 Pfizer,Inc Company Details
11.3.2 Pfizer,Inc Business Overview
11.3.3 Pfizer,Inc Brain Cancer Treatment Introduction
11.3.4 Pfizer,Inc Revenue in Brain Cancer Treatment Business (2017-2022)
11.3.5 Pfizer,Inc Recent Developments
11.4 Y-mAbs Therapeutics,Inc
11.4.1 Y-mAbs Therapeutics,Inc Company Details
11.4.2 Y-mAbs Therapeutics,Inc Business Overview
11.4.3 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Introduction
11.4.4 Y-mAbs Therapeutics,Inc Revenue in Brain Cancer Treatment Business (2017-2022)
11.4.5 Y-mAbs Therapeutics,Inc Recent Developments
11.5 Merck & Co.Inc
11.5.1 Merck & Co.Inc Company Details
11.5.2 Merck & Co.Inc Business Overview
11.5.3 Merck & Co.Inc Brain Cancer Treatment Introduction
11.5.4 Merck & Co.Inc Revenue in Brain Cancer Treatment Business (2017-2022)
11.5.5 Merck & Co.Inc Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Brain Cancer Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Brain Cancer Treatment Business (2017-2022)
11.6.5 Johnson & Johnson Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Brain Cancer Treatment Introduction
11.7.4 AstraZeneca Revenue in Brain Cancer Treatment Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Brain Cancer Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Brain Cancer Treatment Business (2017-2022)
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Amgen Inc
11.9.1 Amgen Inc Company Details
11.9.2 Amgen Inc Business Overview
11.9.3 Amgen Inc Brain Cancer Treatment Introduction
11.9.4 Amgen Inc Revenue in Brain Cancer Treatment Business (2017-2022)
11.9.5 Amgen Inc Recent Developments
11.10 GlaxoSmith Kline PLC
11.10.1 GlaxoSmith Kline PLC Company Details
11.10.2 GlaxoSmith Kline PLC Business Overview
11.10.3 GlaxoSmith Kline PLC Brain Cancer Treatment Introduction
11.10.4 GlaxoSmith Kline PLC Revenue in Brain Cancer Treatment Business (2017-2022)
11.10.5 GlaxoSmith Kline PLC Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Brain Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Others
Table 6. Global Brain Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Brain Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Brain Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Brain Cancer Treatment Market Share by Region (2017-2022)
Table 10. Global Brain Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Brain Cancer Treatment Market Share by Region (2023-2028)
Table 12. Brain Cancer Treatment Market Trends
Table 13. Brain Cancer Treatment Market Drivers
Table 14. Brain Cancer Treatment Market Challenges
Table 15. Brain Cancer Treatment Market Restraints
Table 16. Global Brain Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Brain Cancer Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Brain Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Treatment as of 2021)
Table 19. Ranking of Global Top Brain Cancer Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Brain Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Brain Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Brain Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brain Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Brain Cancer Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Brain Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Brain Cancer Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Brain Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Brain Cancer Treatment Revenue Share by Application (2017-2022)
Table 31. Global Brain Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Brain Cancer Treatment Revenue Share by Application (2023-2028)
Table 33. North America Brain Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Brain Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Brain Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Brain Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Brain Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Brain Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Brain Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Brain Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Brain Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Brain Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Brain Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Brain Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Brain Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Brain Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Brain Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Brain Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Brain Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Brain Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Brain Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Brain Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Brain Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Brain Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Brain Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Brain Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Brain Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Brain Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Brain Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Brain Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Brain Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Brain Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Brain Cancer Treatment Product
Table 66. Novartis AG Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 67. Novartis AG Recent Developments
Table 68. F. Hoffmann-La Roche Ltd Company Details
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Product
Table 71. F. Hoffmann-La Roche Ltd Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd Recent Developments
Table 73. Pfizer,Inc Company Details
Table 74. Pfizer,Inc Business Overview
Table 75. Pfizer,Inc Brain Cancer Treatment Product
Table 76. Pfizer,Inc Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 77. Pfizer,Inc Recent Developments
Table 78. Y-mAbs Therapeutics,Inc Company Details
Table 79. Y-mAbs Therapeutics,Inc Business Overview
Table 80. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Product
Table 81. Y-mAbs Therapeutics,Inc Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 82. Y-mAbs Therapeutics,Inc Recent Developments
Table 83. Merck & Co.Inc Company Details
Table 84. Merck & Co.Inc Business Overview
Table 85. Merck & Co.Inc Brain Cancer Treatment Product
Table 86. Merck & Co.Inc Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 87. Merck & Co.Inc Recent Developments
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Brain Cancer Treatment Product
Table 91. Johnson & Johnson Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 92. Johnson & Johnson Recent Developments
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Brain Cancer Treatment Product
Table 96. AstraZeneca Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 97. AstraZeneca Recent Developments
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Brain Cancer Treatment Product
Table 101. Bristol-Myers Squibb Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Developments
Table 103. Amgen Inc Company Details
Table 104. Amgen Inc Business Overview
Table 105. Amgen Inc Brain Cancer Treatment Product
Table 106. Amgen Inc Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 107. Amgen Inc Recent Developments
Table 108. GlaxoSmith Kline PLC Company Details
Table 109. GlaxoSmith Kline PLC Business Overview
Table 110. GlaxoSmith Kline PLC Brain Cancer Treatment Product
Table 111. GlaxoSmith Kline PLC Revenue in Brain Cancer Treatment Business (2017-2022) & (US$ Million)
Table 112. GlaxoSmith Kline PLC Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Cancer Treatment Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Others Features
Figure 6. Global Brain Cancer Treatment Market Share by Application: 2021 VS 2028
Figure 7. Primary Brain Cancer Case Studies
Figure 8. Secondary Brain Cancer Case Studies
Figure 9. Brain Cancer Treatment Report Years Considered
Figure 10. Global Brain Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Brain Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Brain Cancer Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Brain Cancer Treatment Market Share by Players in 2021
Figure 14. Global Top Brain Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Brain Cancer Treatment Revenue in 2021
Figure 16. North America Brain Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Brain Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Brain Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Brain Cancer Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Brain Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Brain Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Brain Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Brain Cancer Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Brain Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Brain Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Brain Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Brain Cancer Treatment Market Size Share by Region (2017-2028)
Figure 36. China Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Brain Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Brain Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Brain Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Brain Cancer Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Brain Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Brain Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Brain Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Brain Cancer Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Brain Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Novartis AG Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 56. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 57. Pfizer,Inc Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 58. Y-mAbs Therapeutics,Inc Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 59. Merck & Co.Inc Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 60. Johnson & Johnson Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 63. Amgen Inc Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 64. GlaxoSmith Kline PLC Revenue Growth Rate in Brain Cancer Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の脳がん治療市場インサイト及び予測（化学療法、免疫療法、標的療法、その他）(Global Brain Cancer Treatment Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の脳がん治療市場インサイト及び予測（化学療法、免疫療法、標的療法、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp